Deprecated
: abs(): Passing null to parameter #1 ($num) of type int|float is deprecated in
/home/individends/public_html/financial_analysis.php
on line
303
Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
95.76%
Operating Margin
45.74%
Net Margin
-23.71%
Efficiency Metrics
Revenue per Expense Ratio
6.16
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
0.00%
Income Tax Rate
9,500,000.0%
EPS
-1.5000000000
Balance Sheet Analysis
Current Ratio
2.05
Cash Ratio
1.92
Working Capital
$102.61M
Debt to Equity
2.27
Debt to Assets
68.53%
Equity Ratio
30.17%
Cash Flow Analysis
Operating Cash Flow Ratio
18.08%
Free Cash Flow Ratio
18.08%
CapEx to Revenue
0.00%
Dividends Paid
$57.35M
Stock Buybacks
$11.26M
Total Shareholder Returns
$68.61M
Cash Position Change
42.13%
Key Takeaways (2023 FY)
Increased R&D investment by 100.00%
Detailed Growth Metrics
Core Performance
Revenue
240.52%
Net Income
-54.80%
EPS
-94.81%
Operating Income
42.86%
Operational Efficiency
R&D Expenses
100.00%
SG&A Expenses
7.35%
Operating Cash Flow
-11.55%
Free Cash Flow
-11.55%
Balance Sheet Health
Assets
-17.58%
Debt
37.93%
Book Value per Share
-10.35%
Inventory
-100.00%
Shareholder Returns
Dividends per Share
-10.63%
Shares Outstanding
-2.58%
Long Term Trends
3Y Revenue/Share
171.27%
5Y Revenue/Share
193.15%
3Y Dividend/Share
79.20%
5Y Dividend/Share
-15.85%